NICE has reviewed this guidance and it is recommended to amend the guidance.
Please find the published review decision here.
As the review decision is to amend the guidance, the amendments to the published NICE guidance will be made in June 2017.
Next review: June 2020
NICE has developed medical technology guidance on the moorLDI2-BI.
NICE medical technology guidance addresses specific technologies notified to NICE by manufacturers. The ‘case for adoption’ recommendations are based on the claimed advantages of introducing the specific technology compared with current management of the condition. This ‘case’ is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. The specific recommendations on individual technologies are not intended to limit use of other relevant technologies which may offer similar advantages.
NICE has said that the moorLDI2-BI can be used to help make decisions about treatment in patients when experienced healthcare professionals aren’t sure about how deep the burn wound is or how long it might take to heal. Hospital teams may want to use the moorLDI2-BI because the evidence showed that decisions about whether to use surgery could be made earlier, meaning less time spent in hospital. It could also reduce the size of areas that are operated on, or avoid the need for surgery completely in some patients who otherwise might have had to have surgery.
This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.